3NX.DU Stock Analysis
3N
Uncovered
Jinxin Fertility Group Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
0.892
Dividend yield
2.04 %
Shares outstanding
2 711.66 B
Website
http://www.jxr-fertility.comJinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan and currently employs 2,637 full-time employees. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.